Evidence map›Paper›PMID 34797853›Full record

ArticlePloS one2021

O-GlcNAc transferase OGT-1 and the ubiquitin ligase EEL-1 modulate seizure susceptibility in C. elegans.

Nirthieca Suthakaran, Jonathan Wiggins, Andrew Giles, Karla J Opperman, Brock Grill, Ken Dawson-Scully

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Atropine reduces aldicarb-induced sensitivity tomicroPublication biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nirthieca SuthakaranDepartment of Biological Sciences, Florida Atlantic University, Boca Raton, Florida, United States of America.ORCID 0000-0003-0432-0493
Jonathan WigginsDepartment of Biological Sciences, Florida Atlantic University, Boca Raton, Florida, United States of America.
Andrew GilesDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida, United States of America.
Karla J OppermanCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Brock GrillCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Ken Dawson-ScullyDepartment of Biological Sciences, Florida Atlantic University, Boca Raton, Florida, United States of America.
Florida Atlantic University · USScripps Research Institute · USUniversity of Washington · US

Funding

Mechanisms of synapse formation and axon termination in C. elegansR01NS072129 · NINDS · UNIVERSITY OF MINNESOTA · PI GRILL, BROCK · 2011 to 2024
$8.0M
Synthesis of a Bridged Bicyclic Natural Product Using Allenyl EstersR15GM110651 · NIGMS · FLORIDA ATLANTIC UNIVERSITY · PI LEPORE, SALVATORE D · 2014 to 2020
$1.2M
NIGMS NIH HHS R15 GM110651NINDS NIH HHS R01 NS072129
6 · The paper itself

Abstract

Neurodevelopmental disorders such as epilepsy and autism have been linked to an imbalance of excitation and inhibition (E/I) in the central nervous system. The simplicity and tractability of C. elegans allows our electroconvulsive seizure (ES) assay to be used as a behavioral readout of the locomotor circuit and neuronal function. C. elegans possess conserved nervous system features such as gamma-aminobutyric acid (GABA) and GABA receptors in inhibitory neurotransmission, and acetylcholine (Ach) and acetylcholine receptors in excitatory neurotransmission. Our previously published data has shown that decreasing inhibition in the motor circuit, via GABAergic manipulation, will extend the time of locomotor recovery following electroshock. Similarly, mutations in a HECT E3 ubiquitin ligase called EEL-1 leads to impaired GABAergic transmission, E/I imbalance and altered sensitivity to electroshock. Mutations in the human ortholog of EEL-1, called HUWE1, are associated with both syndromic and non-syndromic intellectual disability. Both EEL-1 and its previously established binding protein, OGT-1, are expressed in GABAergic motor neurons, localize to GABAergic presynaptic terminals, and function in parallel to regulate GABA neuron function. In this study, we tested behavioral responses to electroshock in wildtype, ogt-1, eel-1 and ogt-1; eel-1 double mutants. Both ogt-1 and eel-1 null mutants have decreased inhibitory GABAergic neuron function and increased electroshock sensitivity. Consistent with EEL-1 and OGT-1 functioning in parallel pathways, ogt-1; eel-1 double mutants showed enhanced electroshock susceptibility. Expression of OGT-1 in the C. elegans nervous system rescued enhanced electroshock defects in ogt-1; eel-1 double mutants. Application of a GABA agonist, Baclofen, decreased electroshock susceptibility in all animals. Our C. elegans electroconvulsive seizure assay was the first to model a human X-linked Intellectual Disability (XLID) associated with epilepsy and suggests a potential novel role for the OGT-1/EEL-1 complex in seizure susceptibility.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDisease SusceptibilityGABAergic Neuronsgamma-Aminobutyric AcidGenes, X-LinkedGenetic Predisposition to DiseaseIntellectual DisabilityN-AcetylglucosaminyltransferasesNervous SystemNervous System Physiological PhenomenaPresynaptic TerminalsSeizuresSynaptic TransmissionUbiquitinCaenorhabditis elegans ProteinsEEL-1 protein, C elegansgamma-Aminobutyric AcidN-AcetylglucosaminyltransferasesO-GlcNAc transferaseogt-1 protein, C elegansUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID34797853
PMCPMC8604358
OpenAlexW3211504727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.